Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Recruiting	Phase 2	2026-09-02		NCT05571059

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cumberland Pharmaceuticals	4

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Avera Research Institute	Sioux Falls	United States	7
Baylor University Medical Center	Dallas	United States	87
Beaumont Hospital, Royal Oak	Royal Oak	United States	4
Bend Memorial Hospital	Bend	United States	1
Biosolutions Clinical Research	La Mesa	United States	1
Icahn School of Medicine at Mount Sinai	New York	United States	342
Indiana University Health	Indianapolis	United States	28
Mayo Clinic Jacksonville	Jacksonville	United States	67
Miami VA Health System	Miami	United States	1
Northwestern Medicine	Chicago	United States	36
Premier Pulmonary Critical Care and Sleep Medicine	Denison	United States	4
Pulmonary & Sleep Specialists	Dickson	United States	2
Temple University Hospital	Philadelphia	United States	97
Uconn Health	Farmington	United States	26
UNC Chapel Hill	Chapel Hill	United States	6
University of California San Francisco	San Francisco	United States	144
University of Kansas	Kansas City	United States	15
University of Louisville	Louisville	United States	83
University of Rochester	Rochester	United States	360
UW Health University Hospital	Madison	United States	7

Clinical trials